Analyst: This Biotech Stock Could Triple

ZSAN shares are higher after Cantor Fitzgerald issued a lofty price target

Apr 23, 2019 at 1:05 PM
facebook twitter linkedin

Zosano Pharma Corp (NASDAQ:ZSAN) shares are higher today, after analysts at Cantor Fitzgerald initiated coverage with an "outperform" rating and $12 price target -- more than triple yesterday's ZSAN close of $3.66. The brokerage firm last night waxed optimistic on Zosano's ADAM technology and Qtrypta drug, the latter of which Cantor expects to be approved to treat acute migraine in 2020.

ZSAN stock was last seen 6.8% higher at $3.91, set to end back atop its 200-day moving average for the first time since an April 9 bear gap -- the result of a planned stock offering from Zosano. Still, the equity has quite a ways to go before closing that gap, not to mention getting back within striking distance of its Feb. 21 high of $6.65, which stemmed from encouraging Qtrypta data. The overhead $4-$4.40 area could give ZSAN some trouble, too, as this region capped the stock's upside momentum in 2018.

ZSAN stock chart april 23

Even before Cantor weighed in, ZSAN was no stranger to upbeat analyst attention. The consensus 12-month price target of $13 represents a premium of more than 230% to the equity's current price. Meanwhile, all three brokerage firms following the stock consider it a "buy" or better. However, another round of upbeat analyst initiations could help ZSAN fill the aforementioned bear gap.



Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners